オンコリスバイオファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/08/19 | 1,203 | 1,250 | 1,203 | 1,206 | -14 | -1.1% | 147,800 |
| 2021/08/18 | 1,185 | 1,221 | 1,180 | 1,220 | +37 | +3.1% | 154,900 |
| 2021/08/17 | 1,216 | 1,230 | 1,180 | 1,183 | -28 | -2.3% | 170,100 |
| 2021/08/16 | 1,239 | 1,243 | 1,200 | 1,211 | -34 | -2.7% | 175,100 |
| 2021/08/13 | 1,226 | 1,251 | 1,226 | 1,245 | +7 | +0.6% | 126,700 |
| 2021/08/12 | 1,240 | 1,256 | 1,213 | 1,238 | -2 | -0.2% | 180,400 |
| 2021/08/11 | 1,202 | 1,243 | 1,201 | 1,240 | +21 | +1.7% | 183,000 |
| 2021/08/10 | 1,158 | 1,228 | 1,125 | 1,219 | +61 | +5.3% | 334,600 |
| 2021/08/06 | 1,179 | 1,195 | 1,155 | 1,158 | -27 | -2.3% | 250,600 |
| 2021/08/05 | 1,224 | 1,239 | 1,178 | 1,185 | -39 | -3.2% | 291,900 |
| 2021/08/04 | 1,276 | 1,282 | 1,215 | 1,224 | -50 | -3.9% | 275,500 |
| 2021/08/03 | 1,257 | 1,279 | 1,254 | 1,274 | +12 | +1% | 132,400 |
| 2021/08/02 | 1,240 | 1,262 | 1,229 | 1,262 | +16 | +1.3% | 164,800 |
| 2021/07/30 | 1,290 | 1,290 | 1,227 | 1,246 | -35 | -2.7% | 261,500 |
| 2021/07/29 | 1,290 | 1,300 | 1,255 | 1,281 | -8 | -0.6% | 269,300 |
| 2021/07/28 | 1,340 | 1,376 | 1,278 | 1,289 | -51 | -3.8% | 696,400 |
| 2021/07/27 | 1,340 | 1,356 | 1,302 | 1,340 | +41 | +3.2% | 510,800 |
| 2021/07/26 | 1,320 | 1,324 | 1,288 | 1,299 | -11 | -0.8% | 231,100 |
| 2021/07/21 | 1,301 | 1,330 | 1,292 | 1,310 | +23 | +1.8% | 289,900 |
| 2021/07/20 | 1,299 | 1,358 | 1,285 | 1,287 | +15 | +1.2% | 840,700 |
| 2021/07/19 | 1,301 | 1,303 | 1,248 | 1,272 | -29 | -2.2% | 280,400 |
| 2021/07/16 | 1,302 | 1,319 | 1,271 | 1,301 | -1 | -0.1% | 235,300 |
| 2021/07/15 | 1,350 | 1,350 | 1,286 | 1,302 | -52 | -3.8% | 395,800 |
| 2021/07/14 | 1,358 | 1,362 | 1,338 | 1,354 | -4 | -0.3% | 159,400 |
| 2021/07/13 | 1,384 | 1,394 | 1,335 | 1,358 | -22 | -1.6% | 299,300 |
| 2021/07/12 | 1,372 | 1,402 | 1,363 | 1,380 | -8 | -0.6% | 209,800 |
| 2021/07/09 | 1,352 | 1,412 | 1,352 | 1,388 | +14 | +1% | 384,700 |
| 2021/07/08 | 1,405 | 1,406 | 1,362 | 1,374 | -50 | -3.5% | 406,700 |
| 2021/07/07 | 1,444 | 1,460 | 1,410 | 1,424 | -33 | -2.3% | 328,000 |
| 2021/07/06 | 1,441 | 1,480 | 1,411 | 1,457 | +6 | +0.4% | 471,500 |
| 2021/07/05 | 1,475 | 1,514 | 1,441 | 1,451 | +11 | +0.8% | 646,700 |
| 2021/07/02 | 1,578 | 1,585 | 1,426 | 1,440 | -113 | -7.3% | 1,439,400 |
| 2021/07/01 | 1,553 | 1,602 | 1,534 | 1,553 | -2 | -0.1% | 655,400 |
| 2021/06/30 | 1,652 | 1,655 | 1,533 | 1,555 | -71 | -4.4% | 1,136,500 |
| 2021/06/29 | 1,738 | 1,743 | 1,608 | 1,626 | -76 | -4.5% | 1,070,600 |
| 2021/06/28 | 1,837 | 1,847 | 1,680 | 1,702 | -145 | -7.9% | 1,494,000 |
| 2021/06/25 | 1,874 | 1,938 | 1,813 | 1,847 | -7 | -0.4% | 1,128,100 |
| 2021/06/24 | 1,866 | 1,918 | 1,811 | 1,854 | -26 | -1.4% | 1,141,200 |
| 2021/06/23 | 1,762 | 1,893 | 1,762 | 1,880 | +127 | +7.2% | 1,191,500 |
| 2021/06/22 | 1,736 | 1,766 | 1,673 | 1,753 | +39 | +2.3% | 780,500 |
| 2021/06/21 | 1,692 | 1,748 | 1,681 | 1,714 | -16 | -0.9% | 537,700 |
| 2021/06/18 | 1,740 | 1,773 | 1,692 | 1,730 | ±0 | ±0% | 760,200 |
| 2021/06/17 | 1,698 | 1,750 | 1,661 | 1,730 | +23 | +1.3% | 1,120,200 |
| 2021/06/16 | 1,583 | 1,722 | 1,562 | 1,707 | +131 | +8.3% | 2,082,700 |
| 2021/06/15 | 1,510 | 1,591 | 1,503 | 1,576 | +53 | +3.5% | 636,400 |
| 2021/06/14 | 1,631 | 1,649 | 1,513 | 1,523 | -14 | -0.9% | 1,718,400 |
| 2021/06/11 | 1,517 | 1,581 | 1,505 | 1,537 | +42 | +2.8% | 685,300 |
| 2021/06/10 | 1,499 | 1,534 | 1,474 | 1,495 | +4 | +0.3% | 433,400 |
| 2021/06/09 | 1,450 | 1,522 | 1,438 | 1,491 | +23 | +1.6% | 554,700 |
| 2021/06/08 | 1,440 | 1,484 | 1,403 | 1,468 | +81 | +5.8% | 784,900 |
801～
850
件表示中 / 2679件
類似銘柄と比較する
現在ご覧いただいている「オンコリス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| オンコリス | 70,300円 | +58.7% | - | 0.00% | - | 12.39倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
| 大幸薬品 | 36,400円 | +11.1% | - | 0.00% | 33.21倍 | 2.26倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
| ヘリオス | 19,600円 | +395.9% | - | 0.00% | - | 5.45倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
| Ｃｈｏｒｄｉａ | 24,900円 | - | - | 0.00% | - | 4.08倍 |
|
ＲＮＡ制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
| ＣＡＮＢＡＳ | 88,700円 | - | - | 0.00% | - | 7.35倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
市場注目の銘柄
チャート関連のコラム
